Squalamine for the Treatment in Proliferative Diabetic Retinopathy
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy in the use of topical Squalamine
Lactate Ophthalmic Solution, 0.2% in the treatment of retinal neovascularization resulting
from proliferative diabetic retinopathy.